Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
J Obes Metab Syndr ; 32(4): 289-302, 2023 Dec 30.
Article in English | MEDLINE | ID: mdl-38049180

ABSTRACT

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease, is characterized by hepatic steatosis and metabolic dysfunction and is often associated with obesity and insulin resistance. Recent research indicates a rapid escalation in MASLD cases, with projections suggesting a doubling in the United States by 2030. This review focuses on the central role of mitochondria in the pathogenesis of MASLD and explores potential therapeutic interventions. Mitochondria are dynamic organelles that orchestrate hepatic energy production and metabolism and are critically involved in MASLD. Dysfunctional mitochondria contribute to lipid accumulation, inflammation, and liver fibrosis. Genetic associations further underscore the relationship between mitochondrial dynamics and MASLD susceptibility. Although U.S. Food and Drug Administration-approved treatments for MASLD remain elusive, ongoing clinical trials have highlighted promising strategies that target mitochondrial dysfunction, including vitamin E, metformin, and glucagon-like peptide-1 receptor agonists. In preclinical studies, novel therapeutics, including nicotinamide adenine dinucleotide+ precursors, urolithin A, spermidine, and mitoquinone, have shown beneficial effects, such as improving mitochondrial quality control, reducing oxidative stress, and ameliorating hepatic steatosis and inflammation. In conclusion, mitochondrial dysfunction is central to MASLD pathogenesis. The innovative mitochondria-targeted approaches discussed in this review offer a promising avenue for reducing the burden of MASLD and improving global quality of life.

2.
Front Oncol ; 13: 1218735, 2023.
Article in English | MEDLINE | ID: mdl-37692839

ABSTRACT

Gastrointestinal malignancies, including colon adenocarcinoma (COAD) and liver hepatocellular carcinoma (LIHC), remain leading causes of cancer-related deaths worldwide. To better understand the underlying mechanisms of these cancers and identify potential therapeutic targets, we analyzed publicly accessible Cancer Genome Atlas datasets of COAD and LIHC. Our analysis revealed that differentially expressed genes (DEGs) during early tumorigenesis were associated with cell cycle regulation. Additionally, genes related to lipid metabolism were significantly enriched in both COAD and LIHC, suggesting a crucial role for dysregulated lipid metabolism in their development and progression. We also identified a subset of DEGs associated with mitochondrial function and structure, including upregulated genes involved in mitochondrial protein import and respiratory complex assembly. Further, we identified mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase (HMGCS2) as a crucial regulator of cancer cell metabolism. Using a genome-scale metabolic model, we demonstrated that HMGCS2 suppression increased glycolysis, lipid biosynthesis, and elongation while decreasing fatty acid oxidation in colon cancer cells. Our study highlights the potential contribution of dysregulated lipid metabolism, including ketogenesis, to COAD and LIHC development and progression and identifies potential therapeutic targets for these malignancies.

3.
Zookeys ; 1169: 163-174, 2023.
Article in English | MEDLINE | ID: mdl-38312320

ABSTRACT

A new species of the genus Pseudaeginella Mayer, 1890 belonging to the family Caprellidae Leach, 1814 was collected from the South Sea in Korea. Pseudaeginellacarinaspinosasp. nov. is morphologically similar to related congeners belonging to the genera Paradeutella Mayer, 1890 and Pseudaeginella, in having dorsal projections on pereonites, triarticulate mandibular palp, small or absent molar, and uniarticulate pereopods 3 and 4. However, this new species is distinguished from its congeners by the position and size of dorsal projection. This is the first record of Pseudaeginella from the Northwest Pacific region, including Korea, and a key to species of the genus Pseudaeginella is also provided.

4.
Nanomaterials (Basel) ; 12(19)2022 Sep 21.
Article in English | MEDLINE | ID: mdl-36234414

ABSTRACT

Dermal delivery, which delivers drugs and cosmetics through the skin, has attracted significant attention due to its non-invasive and simple administration compared with oral or injectable administration. However, delivery of the ingredients through the skin barrier is difficult because the primary function of the skin is to protect the human body by preventing the invasion of contaminants. Although various techniques have been developed to overcome skin barriers, chemical toxicity, complicated processes, and expensive equipment still remain as obstacles. Moreover, green chemistry, which minimizes or eliminates the use of toxic chemicals, is required in the cosmetic industry. Thus, the development of a new method for dermal delivery is required. In this study, we provide a new method for dermal delivery using nanobubbles (NBs). NBs generated in oil improve the delivery effect of the active ingredients through the high Brownian motion and charge-balancing effect. Franz cell experiments and depigmentation experiments using the B16F10 melanoma cells were conducted to confirm the enhanced delivery effects. The system using NBs will contribute to the advancement of the dermal delivery of drugs and cosmetics.

5.
JMIR Mhealth Uhealth ; 8(10): e22080, 2020 10 16.
Article in English | MEDLINE | ID: mdl-33012704

ABSTRACT

BACKGROUND: Tongue pressure is an effective index of swallowing function, and it decreases with aging and disease progression. Previous research has shown beneficial effects of swallowing exercises combined with myofunctional tongue-strengthening therapy on tongue function. Tongue exercises delivered through mobile health (mHealth) technologies have the potential to advance health care in the digital age to be more efficient for people with limited resources, especially older adults. OBJECTIVE: The purpose of this study is to explore the immediate and long-term maintenance effects of an 8-week home-based mHealth app intervention with biweekly (ie, every 2 weeks) human mediation aimed at improving the swallowing tongue pressure in older adults. METHODS: We developed an mHealth app intervention that was used for 8 weeks (3 times/day, 5 days/week, for a total of 120 sessions) by 11 community-dwelling older adults (10 women; mean age 75.7 years) who complained of swallowing difficulties. The app included a swallowing monitoring and intervention protocol with 3 therapy maneuvers: effortful prolonged swallowing, effortful pitch glide, and effortful tongue rotation. The 8-week intervention was mediated by biweekly face-to-face meetings to monitor each participant's progress and ability to implement the training sessions according to the given protocol. Preintervention and postintervention isometric and swallowing tongue pressures were measured using the Iowa Oral Performance Instrument. We also investigated the maintenance effects of the intervention on swallowing tongue pressure at 12 weeks postintervention. RESULTS: Of the 11 participants, 8 adhered to the home-based 8-week app therapy program with the optimal intervention dosage. At the main trial end point (ie, 8 weeks) of the intervention program, the participants demonstrated a significant increase in swallowing tongue pressure (median 17.5 kPa before the intervention and 26.5 kPa after the intervention; P=.046). However, long-term maintenance effects of the training program on swallowing tongue pressure at 12 weeks postintervention were not observed. CONCLUSIONS: Swallowing tongue pressure is known to be closely related to dysphagia symptoms. This is the first study to demonstrate the effectiveness of the combined methods of effortful prolonged swallowing, effortful pitch glide, and effortful tongue rotation using mobile app training accompanied by biweekly human mediation in improving swallowing tongue pressure in older adults. The mHealth app is a promising platform that can be used to deliver effective and convenient therapeutic service to vulnerable older adults. To investigate the therapeutic efficacy with a larger sample size and observe the long-term effects of the intervention program, further studies are warranted. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/19585.


Subject(s)
Mobile Applications , Telemedicine , Aged , Deglutition , Female , Humans , Pressure , Tongue
6.
Cell Death Differ ; 27(4): 1341-1354, 2020 04.
Article in English | MEDLINE | ID: mdl-31527799

ABSTRACT

Notch, an essential factor in tissue development and homoeostasis, has been reported to play an oncogenic function in a variety of cancers. Here, we report ubiquitin-specific protease 8 (USP8) as a novel deubiquitylase of Notch1 intracellular domain (NICD). USP8 specifically stabilizes and deubiquitylates NICD through a direct interaction. The inhibition of USP8 downregulated the Notch signalling pathway via NICD destabilization, resulting in the retardation of cellular growth, wound closure, and colony forming ability of breast cancer cell lines. These phenomena were restored by the reconstitution of NICD or USP8, supporting the direct interaction between these two proteins. The expression levels of NICD and USP8 proteins were positively correlated in patients with advanced breast cancer. Taken together, our results suggest that USP8 functions as a positive regulator of Notch signalling, offering a therapeutic target for breast cancer.


Subject(s)
Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Endopeptidases/metabolism , Endosomal Sorting Complexes Required for Transport/metabolism , Receptor, Notch1/chemistry , Receptor, Notch1/metabolism , Ubiquitin Thiolesterase/metabolism , Ubiquitination , Adult , Aged , Aged, 80 and over , Carcinogenesis , Cell Line, Tumor , Cell Proliferation , Down-Regulation , Female , Gene Deletion , Humans , Middle Aged , Protein Binding , Protein Domains , Protein Stability , Signal Transduction , Tumor Stem Cell Assay , Up-Regulation , Wound Healing
7.
Nutrients ; 11(9)2019 Sep 06.
Article in English | MEDLINE | ID: mdl-31500218

ABSTRACT

Omega-3 polyunsaturated fatty acids (ω3-PUFAs) have potential protective activity in a variety of infectious diseases, but their actions and underlying mechanisms in Toxoplasma gondii infection remain poorly understood. Here, we report that docosahexaenoic acid (DHA) robustly induced autophagy in murine bone marrow-derived macrophages (BMDMs). Treatment of T. gondii-infected macrophages with DHA resulted in colocalization of Toxoplasma parasitophorous vacuoles with autophagosomes and reduced intracellular survival of T. gondii. The autophagic and anti-Toxoplasma effects induced by DHA were mediated by AMP-activated protein kinase (AMPK) signaling. Importantly, BMDMs isolated from Fat-1 transgenic mice, a well-known animal model capable of synthesizing ω3-PUFAs from ω6-PUFAs, showed increased activation of autophagy and AMPK, leading to reduced intracellular survival of T. gondii when compared with wild-type BMDMs. Moreover, Fat-1 transgenic mice exhibited lower cyst burden in the brain following infection with the avirulent strain ME49 than wild-type mice. Collectively, our results revealed mechanisms by which endogenous ω3-PUFAs and DHA control T. gondii infection and suggest that ω3-PUFAs might serve as therapeutic candidate to prevent toxoplasmosis and infection with other intracellular protozoan parasites.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Antiparasitic Agents/pharmacology , Autophagy/drug effects , Docosahexaenoic Acids/pharmacology , Macrophages/drug effects , Toxoplasma/drug effects , Toxoplasmosis, Animal/prevention & control , Toxoplasmosis, Cerebral/prevention & control , Animals , Brain/drug effects , Brain/enzymology , Brain/parasitology , Brain/pathology , Cadherins/genetics , Cadherins/metabolism , Cell Line , Disease Models, Animal , Enzyme Activation , Humans , Macrophages/enzymology , Macrophages/parasitology , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Transgenic , Retinal Pigment Epithelium/drug effects , Retinal Pigment Epithelium/enzymology , Retinal Pigment Epithelium/parasitology , Signal Transduction , Toxoplasma/pathogenicity , Toxoplasmosis, Animal/enzymology , Toxoplasmosis, Animal/parasitology , Toxoplasmosis, Animal/pathology , Toxoplasmosis, Cerebral/enzymology , Toxoplasmosis, Cerebral/parasitology , Toxoplasmosis, Cerebral/pathology
8.
Nat Commun ; 9(1): 3404, 2018 08 24.
Article in English | MEDLINE | ID: mdl-30143610

ABSTRACT

AMP-activated protein kinase (AMPK) plays a key role in controlling energy metabolism in response to physiological and nutritional status. Although AMPK activation has been proposed as a promising molecular target for treating obesity and its related comorbidities, the use of pharmacological AMPK activators has been met with contradictory therapeutic challenges. Here we show a regulatory mechanism for AMPK through its ubiquitination and degradation by the E3 ubiquitin ligase makorin ring finger protein 1 (MKRN1). MKRN1 depletion promotes glucose consumption and suppresses lipid accumulation due to AMPK stabilisation and activation. Accordingly, MKRN1-null mice show chronic AMPK activation in both liver and adipose tissue, resulting in significant suppression of diet-induced metabolic syndrome. We demonstrate also its therapeutic effect by administering shRNA targeting MKRN1 into obese mice that reverses non-alcoholic fatty liver disease. We suggest that ubiquitin-dependent AMPK degradation represents a target therapeutic strategy for metabolic disorders.


Subject(s)
Metabolic Syndrome/metabolism , Ribonucleoproteins/metabolism , Ubiquitin-Protein Ligases/metabolism , AMP-Activated Protein Kinases/genetics , AMP-Activated Protein Kinases/metabolism , Adipocytes/metabolism , Adipocytes/pathology , Animals , Diet, High-Fat/adverse effects , Fatty Liver/genetics , Fatty Liver/metabolism , Female , Liver/metabolism , Liver/pathology , Male , Metabolic Syndrome/genetics , Mice , Mice, Knockout , Non-alcoholic Fatty Liver Disease/etiology , Non-alcoholic Fatty Liver Disease/metabolism , Ribonucleoproteins/genetics , Ubiquitin-Protein Ligases/genetics
9.
Oncol Rep ; 39(1): 239-246, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29192322

ABSTRACT

Among brain tumors, glioblastoma (GBM) is the most aggressive type and is associated with the lowest patient survival rate. Numerous lines of evidence have established that omega-3-polyunsaturated fatty acids (ω3-PUFAs) have potential for the prevention and therapy of several types of cancers. Docosahexaenoic acid (DHA), an ω3-PUFA, was reported to inhibit growth and induce apoptotic and autophagic cell death in several cancer cell lines; however, its effects on GBM cells are still unknown. in the present study, we examined the cytotoxic effect of DHA on the GBM cell lines, D54MG, U87MG, U251MG and GL261. Treatment of GBM cells with DHA induced PARP cleavage, increased the population of sub-G1 cells, and increased the number of TUNEL-positive cells, which are all indicative of apoptosis. Furthermore, treatment of GBM cells with DHA resulted in a significant increase in autophagic activity, as revealed by increased LC3-II levels, GFP-LC3 puncta, and autophagic flux activation, accompanied by activation of 5'-AMP-activated protein kinase (AMPK) and decreases in phosphorylated Akt (p-AktSer473) levels and mTOR activity. In vivo, endogenous expression of Caenorhabditis elegans ω3-desaturase, which converts ω6-PUFAs to ω3-PUFAs, in fat-1 transgenic mice yielded a significant decrease in tumor volume following subcutaneous injection of mouse glioma cells (GL261), when compared with wild-type mice. TUNEL-positive cell numbers and LC3-II levels were elevated in tumor tissue from the fat-1 transgenic mice compared with tumor tissue from the wild-type mice. In addition, p-Akt levels were decreased and p-AMPK levels were increased in tumor tissue from the fat-1 transgenic mice. These results indicate that ω3-PUFAs induce cell death through apoptosis and autophagy in GBM cells; thus, it may be possible to use ω3-PUFAs as chemopreventive and therapeutic agents for GBM.


Subject(s)
Antineoplastic Agents/administration & dosage , Brain Neoplasms/drug therapy , Docosahexaenoic Acids/administration & dosage , Fatty Acid Desaturases/genetics , Glioblastoma/drug therapy , AMP-Activated Protein Kinases/metabolism , Animals , Antineoplastic Agents/pharmacology , Apoptosis , Autophagy , Brain Neoplasms/metabolism , Caenorhabditis elegans/enzymology , Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans Proteins/metabolism , Cell Line, Tumor , Cell Survival/drug effects , Docosahexaenoic Acids/pharmacology , Fatty Acid Desaturases/metabolism , Gene Expression Regulation, Neoplastic/drug effects , Glioblastoma/metabolism , Humans , Mice , Mice, Transgenic , Phosphorylation , Poly(ADP-ribose) Polymerases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Xenograft Model Antitumor Assays
10.
Anticancer Res ; 37(10): 5415-5423, 2017 10.
Article in English | MEDLINE | ID: mdl-28982851

ABSTRACT

Unopposed phosphoinositide 3-kinase (PI3K) activity and 3-phosphoinositide production in Jurkat cells, due to a mutation in the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) tumor-suppressor protein, results in deregulation of PH domain-containing proteins including the serine/threonine kinase PKB. In Jurkat cells, PKB is constitutively active and phosphorylated at the activation-loop residue (Thr308). 3-Phosphoinositide-dependent protein kinase-1 (PDK1), an enzyme that also contains a PH domain, catalyses Thr308 phosphorylation of PKB in addition to other kinase families such as PKC isoforms. It is unknown, however, whether the loss of PTEN in Jurkat cells also results in unregulated PDK1 activity and whether such loss has an impact on activation-loop phosphorylation of other PDK1 substrates e.g. PKC. In this study, we addressed whether loss of PTEN in Jurkat cells affects PDK1 catalytic activity and intracellular localization. We demonstrated that reducing the level of 3-phosphoinositides in Jurkat cells with pharmacological inhibitors of PI3K or expression of PTEN does not affect PDK1 activity or its intracellular localization. We conclude, therefore, that although Jurkat cells lack PTEN expression, only a subset of pathways downstream of PDK1 are perturbed as a consequence of PTEN loss.


Subject(s)
3-Phosphoinositide-Dependent Protein Kinases/metabolism , Leukemia, T-Cell/enzymology , PTEN Phosphohydrolase/metabolism , Phosphatidylinositol 3-Kinase/metabolism , Catalysis , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Humans , Jurkat Cells , Leukemia, T-Cell/genetics , Leukemia, T-Cell/pathology , PTEN Phosphohydrolase/genetics , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation , Protein Kinase Inhibitors/pharmacology , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction , Time Factors , Transfection
11.
J Microbiol Biotechnol ; 27(10): 1736-1743, 2017 Oct 28.
Article in English | MEDLINE | ID: mdl-28813780

ABSTRACT

Sourdough is made by fermentation of dough by lactic acid bacteria (LAB) and yeast to improve bread properties like volume, flavor, and texture. A Korean traditional sourdough was made by fermenting rice flour with rice wine (makgeolli) and used to make sponge-like bread (jeung-pyun). The aim of this study was to investigate the microbial diversity of makgeolli products and their influence on the organoleptic quality of jeung-pyun. Three commercial makgeolli were tested for jeung-pyun production, with each product exhibiting varied dough swelling rates and organoleptic qualities, and among them, J-product was ranked highest in texture and taste. Microbial analysis of the three makgeolli also showed a big difference in their population and diversity. J-product had the highest LAB and yeast counts, and the predominant species were Lactobacillus casei, Lactobacillus brevis, Leuconostoc pseudomenteroides, and Saccharomyces cerevisiae. Using J-product, sourdough was fermented at 25°C, 30°C, and 35°C, and the microbial growth in and textural properties of jeung-pyun were examined by instrumental and sensory tests. At high temperature (35°C), the rates of dough swelling and acidification were fast due to rapid microbial growth mainly caused by LAB, resulting in a short leavening time and soft and sour jeung-pyun. Sensory tests showed consumer preference for the soft and mild-sour jeung-pyun. This study shows that LAB in makgeolli play key roles in production of jeung-pyun, influencing the textural and sensory properties. For the production of high-quality jeung-pyun, development of LAB starters with high gas productivity and low acidity and establishment of an optimal fermentation procedure for rice dough are necessary.


Subject(s)
Alcoholic Beverages/microbiology , Biodiversity , Food Microbiology , Lactobacillales/classification , Lactobacillales/isolation & purification , Oryza/microbiology , Sensation , Alcoholic Beverages/analysis , Bread , DNA, Bacterial , Fermentation , Flour/analysis , Flour/microbiology , Hydrogen-Ion Concentration , Lactobacillales/growth & development , Lactobacillales/metabolism , Phylogeny , RNA, Ribosomal, 16S , Temperature , Wine/microbiology
12.
Sci Rep ; 7: 40023, 2017 01 06.
Article in English | MEDLINE | ID: mdl-28059128

ABSTRACT

PPARγ (Peroxisome proliferator-activated receptor γ) is a nuclear receptor involved in lipid homeostasis and related metabolic diseases. Acting as a transcription factor, PPARγ is a master regulator for adipocyte differentiation. Here, we reveal that CHIP (C-terminus of HSC70-interacting protein) suppresses adipocyte differentiation by functioning as an E3 ligase of PPARγ. CHIP directly binds to and induces ubiquitylation of the PPARγ protein, leading to proteasome-dependent degradation. Stable overexpression or knockdown of CHIP inhibited or promoted adipogenesis, respectively, in 3T3-L1 cells. On the other hand, a CHIP mutant defective in E3 ligase could neither regulate PPARγ protein levels nor suppress adipogenesis, indicating the importance of CHIP-mediated ubiquitylation of PPARγ in adipocyte differentiation. Lastly, a CHIP null embryo fibroblast exhibited augmented adipocyte differentiation with increases in PPARγ and its target protein levels. In conclusion, CHIP acts as an E3 ligase of PPARγ, suppressing PPARγ-mediated adipogenesis.


Subject(s)
Adipocytes/cytology , PPAR gamma/metabolism , Ubiquitin-Protein Ligases/chemistry , Ubiquitin-Protein Ligases/metabolism , 3T3-L1 Cells , Adipocytes/metabolism , Adipogenesis , Animals , Binding Sites , Cell Differentiation , Cell Line , Gene Expression Regulation , HEK293 Cells , Humans , Mice , PPAR gamma/chemistry , Proteasome Endopeptidase Complex/metabolism , Protein Binding , Proteolysis , Ubiquitin/metabolism , Ubiquitin-Protein Ligases/genetics
13.
Oncotarget ; 7(31): 49961-49971, 2016 Aug 02.
Article in English | MEDLINE | ID: mdl-27363023

ABSTRACT

Breast cancer is one of the most prevalent cancers in women, and nearly half of breast cancer patients develop distant metastatic disease after therapy. Despite the significant advances that have been achieved in understanding breast cancer metastasis in the past decades, metastatic cancer is still hard to cure. Here, we demonstrated an anti-cancer mechanism of docosahexaenoic acid (DHA) that suppressed lung metastasis in breast cancer. DHA could inhibit proliferation and invasion of breast cancer cells in vitro, and this was mainly through blocking Cox-2-PGE2-NF-κB-MMPs cascades. DHA treatment significantly decreased Cox-2 and NF-κB expression as well as nuclear translocation of NF-κB in MDA-MB-231 cells. In addition, DHA also reduced NF-κB binding to DNA which may lead to inactivation of MMPs. Moreover, in vivo studies using Fat-1 transgenic mice showed remarkable decrease of tumor growth and metastasis to EO771 cells to lung in DHA-rich environment. In conclusion, DHA attenuated breast cancer progression and lung metastasis in part through suppressing MMPs, and these findings suggest chemoprevention and potential therapeutic strategy to overcome malignant breast cancer.


Subject(s)
Breast Neoplasms/drug therapy , Docosahexaenoic Acids/pharmacology , Matrix Metalloproteinase Inhibitors/pharmacology , Neoplasm Metastasis/prevention & control , Active Transport, Cell Nucleus , Animals , Apoptosis , Breast Neoplasms/pathology , Cell Line, Tumor , Cell Movement , Cell Proliferation , Cell Survival , Culture Media, Conditioned , Cyclooxygenase 2/metabolism , Dinoprostone/antagonists & inhibitors , Disease Progression , Female , Gene Expression Regulation, Neoplastic/drug effects , Humans , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , NF-kappa B/metabolism , Neoplasm Invasiveness
14.
J Agric Food Chem ; 64(12): 2506-12, 2016 Mar 30.
Article in English | MEDLINE | ID: mdl-26494255

ABSTRACT

This study aimed to produce a pharmacologically active minor ginsenoside F2 from the major ginsenosides Rb1 and Rd by using a recombinant Lactococcus lactis strain expressing a heterologous ß-glucosidase gene. The nucleotide sequence of the gene (BglPm) was derived from Paenibacillus mucilaginosus and synthesized after codon optimization, and the two genes (unoptimized and optimized) were expressed in L. lactis NZ9000. Codon optimization resulted in reduction of unfavorable codons by 50% and a considerable increase in the expression levels (total activities) of ß-glucosidases (0.002 unit/mL, unoptimized; 0.022 unit/mL, optimized). The molecular weight of the enzyme was 52 kDa, and the purified forms of the enzymes could successfully convert Rb1 and Rd into F2. The permeabilized L. lactis expressing BglPm resulted in a high conversion yield (74%) of F2 from the ginseng extract. Utilization of this microbial cell to produce F2 may provide an alternative method to increase the health benefits of Panax ginseng.


Subject(s)
Ginsenosides/analysis , Lactococcus lactis/metabolism , Paenibacillus/chemistry , beta-Glucosidase/metabolism , Bacillus/metabolism , Lactococcus lactis/genetics , Molecular Structure , Molecular Weight , Paenibacillus/enzymology , Paenibacillus/genetics , Panax/metabolism , Xylenes/chemistry , beta-Glucosidase/genetics
15.
Biomed Res Int ; 2015: 239764, 2015.
Article in English | MEDLINE | ID: mdl-26339598

ABSTRACT

The anticancer properties and mechanism of action of omega-3 polyunsaturated fatty acids (ω3-PUFAs) have been demonstrated in several cancers; however, the mechanism in lung cancer remains unclear. Here, we show that docosahexaenoic acid (DHA), a ω3-PUFA, induced apoptosis and autophagy in non-small cell lung cancer (NSCLC) cells. DHA-induced cell death was accompanied by AMP-activated protein kinase (AMPK) activation and inactivated phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling. Knocking down AMPK and overexpressing Akt increased mTOR activity and attenuated DHA-induced cell death, suggesting that DHA induces cell death via AMPK- and Akt-regulated mTOR inactivation. This was confirmed in Fat-1 transgenic mice, which produce ω3-PUFAs. Lewis lung cancer (LLC) tumor cells implanted into Fat-1 mice showed slower growth, lower phospho-Akt levels, and higher levels of apoptosis and autophagy than cells implanted into wild-type mice. Taken together, these data suggest that DHA-induced apoptosis and autophagy in NSCLC cells are associated with AMPK activation and PI3K/Akt inhibition, which in turn lead to suppression of mTOR; thus ω3-PUFAs may be utilized as potential therapeutic agents for NSCLC treatment.


Subject(s)
AMP-Activated Protein Kinases/genetics , Carcinoma, Non-Small-Cell Lung/drug therapy , Docosahexaenoic Acids/administration & dosage , Proto-Oncogene Proteins c-akt/genetics , TOR Serine-Threonine Kinases/genetics , AMP-Activated Protein Kinases/biosynthesis , Animals , Apoptosis/drug effects , Autophagy/drug effects , Carcinoma, Non-Small-Cell Lung/genetics , Carcinoma, Non-Small-Cell Lung/pathology , Cell Line, Tumor , Humans , Mice , Mice, Transgenic , Phosphatidylinositol 3-Kinases/genetics , Phosphoinositide-3 Kinase Inhibitors , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Signal Transduction/drug effects , TOR Serine-Threonine Kinases/biosynthesis
16.
J Microbiol Biotechnol ; 25(12): 2100-5, 2015 Dec 28.
Article in English | MEDLINE | ID: mdl-26282688

ABSTRACT

Probiotic bacteria must have not only tolerance against bile salt but also no genes for antibiotic resistance. Leuconostoc citreum is a dominant lactic acid bacterium in various fermented foods, but it is not regarded as a probiotic because it lacks bile salt resistance. Therefore, we aimed to construct a bile salt-resistant L. citreum strain by transforming it with a bile salt hydrolase gene (bsh). We obtained the 1,001 bp bsh gene from the chromosomal DNA of Lactobacillus plantarum and subcloned it into the pCB4170 vector under a constitutive P710 promoter. The resulting vector, pCB4170BSH was transformed into L. citreum CB2567 by electroporation, and bile saltresistant transformants were selected. Upon incubation with glycodeoxycholic acid sodium salt (GDCA), the L. citreum transformants grew and formed colonies, successfully transcribed the bsh gene, and expressed the BSH enzyme. The recombinant strain grew in up to 0.3% (w/v) GDCA, conditions unsuitable for the host strain. In in vitro digestion conditions of 10 mM bile salt, the transformant was over 67.6% viable, whereas only 0.8% of the host strain survived.


Subject(s)
Amidohydrolases/metabolism , Bile Acids and Salts/toxicity , Drug Resistance, Bacterial , Leuconostoc/drug effects , Leuconostoc/growth & development , Probiotics , Recombinant Proteins/metabolism , Amidohydrolases/genetics , Bile Acids and Salts/metabolism , Cloning, Molecular , Culture Media/chemistry , Gene Expression , Lactobacillus plantarum/enzymology , Lactobacillus plantarum/genetics , Leuconostoc/enzymology , Leuconostoc/genetics , Microbial Viability/drug effects , Recombinant Proteins/genetics , Transformation, Genetic
17.
Biopolymers ; 103(6): 321-7, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25652688

ABSTRACT

The aim of this study was to isolate dextran-hydrolyzing bacteria from the human intestines and to identify their dextranolytic enzymes. For this, dextranase-producing microorganisms were screened from fecal samples by using blue dextran-containing media. Colonies producing a decolorized zone were isolated and they were grouped using RAPD-PCR. 16S rRNA gene sequencing analysis revealed the isolates were Bacteroides (B.) thetaiotaomicron, B. ovatus, B. vulgatus, B. dorei, B. xylanisolvens, B. uniformis, and Veillonella (V.) rogosae. Thin layer chromatography analysis showed that the dextranases exhibit mainly endo-type activity and produce various oligosaccharides including isomaltose and isomaltotriose. Zymogram analysis demonstrated that enzymes localized mainly in the cell membrane fraction and the molecular weight was 50-70 kDa. When cultured in a dextran-containing medium, all strains isolated in this study produced short-chain fatty acids, with butyric acid as the major compound. This is the first study to report that human intestinal B. xylanisolvens, B. dorei, and V. rogosae metabolize dextran utilizing dextranolytic enzymes.


Subject(s)
Bacteria/metabolism , Dextrans/metabolism , Intestines/microbiology , Dextranase/metabolism , Humans , Oligosaccharides/metabolism
18.
Int J Food Microbiol ; 200: 80-6, 2015 May 04.
Article in English | MEDLINE | ID: mdl-25702881

ABSTRACT

Lactobacillus sanfranciscensis is a bacterium used in sourdough that provides desirable properties such as better flavor and texture to the sourdough bread. Here, the intra-species diversity of L. sanfranciscensis strains isolated from Korean sourdough was studied using genotypic (multiplex-RAPD-PCR: multiplex-Randomly Amplified Polymorphic DNA-polymerase chain reaction) and phenotypic (VITEK2 Compact system) analyses. For this, a novel species-specific set of PCR primers was developed to identify L. sanfranciscensis using the recently published genome database. The primers were able to detect L. sanfranciscensis isolated from Korean sourdough with 100% accuracy. Genotyping and phenotyping analyses at the strain level demonstrated that Korean sourdough possesses various biotypes of L. sanfranciscensis strains. These strains were clustered into 5 subtypes (genotyping) or 7 subtypes (phenotyping). In summary, this strategy to construct novel primers reduced the chance of cross amplification and was able to identify the desired strain. The various strains isolated in this study can be used to develop a sourdough starter after the analysis of their fermentation characteristics.


Subject(s)
Bread/microbiology , Food Microbiology , Lactobacillus/genetics , DNA Primers/genetics , Genotype , Lactobacillus/classification , Lactobacillus/isolation & purification , Multiplex Polymerase Chain Reaction , Polymerase Chain Reaction , Species Specificity
19.
Biochem Biophys Res Commun ; 457(1): 95-100, 2015 Jan 30.
Article in English | MEDLINE | ID: mdl-25545062

ABSTRACT

Omega-3 polyunsaturated fatty acid levels are reduced in the substantia nigra area in Parkinson's disease patients and animal models, implicating docosahexaenoic acid (DHA) as a potential treatment for preventing Parkinson's disease and suggesting the need for investigations into how DHA might protect against neurotoxin-induced dopaminergic neuron loss. The herbicide paraquat (PQ) induces dopaminergic neuron loss through the excessive production of reactive oxygen species (ROS). We found that treatment of dopaminergic SN4741 cells with PQ reduced cell viability in a dose-dependent manner, but pretreatment with DHA ameliorated the toxic effect of PQ. To determine the toxic mechanism of PQ, we measured intracellular ROS content in different organelles with specific dyes. As expected, all types of ROS were increased by PQ treatment, but DHA pretreatment selectively decreased cytosolic hydrogen peroxide content. Furthermore, DHA treatment-induced increases in glutathione reductase and glutamate cysteine ligase modifier subunit (GCLm) mRNA expression were positively correlated with glutathione (GSH) content. Consistent with this increase in GCLm mRNA levels, Western blot analysis revealed that DHA pretreatment increased nuclear factor-erythroid 2 related factor 2 (Nrf2) protein levels. These findings indicate that DHA prevents PQ-induced neuronal cell loss by enhancing Nrf2-regulated GSH homeostasis.


Subject(s)
Docosahexaenoic Acids/pharmacology , Dopaminergic Neurons/metabolism , Glutathione/metabolism , Homeostasis/drug effects , Paraquat/toxicity , Reactive Oxygen Species/metabolism , Animals , Cell Death/drug effects , Cell Line , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/enzymology , Glutathione Reductase/metabolism , Mice , NF-E2-Related Factor 2/metabolism , Neuroprotective Agents/pharmacology
20.
J Ind Microbiol Biotechnol ; 42(1): 49-55, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25475752

ABSTRACT

The aim of this study was to develop a competitive quantitative-PCR (CQ-PCR) method for rapid analysis of the population dynamics of lactic acid bacteria (LAB) in kimchi. For this, whole chromosome sequences of Leuconostoc mesenteroides, Lactobacillus plantarum, and Lb. brevis were compared and species-specific PCR primers targeting dextransucrase, 16S rRNA, and surface layer protein D (SlpD) genes, respectively, were constructed. The tested strains were quantified both in medium and kimchi by CQ-PCR and the results were compared with the data obtained using a conventional plate-counting method. As a result, the three species were successfully detected and quantified by the indicated primer sets. Our results show that the CQ-PCR method targeting species-specific genes is suitable for rapid estimation of LAB population to be used in the food fermentation industry.


Subject(s)
Fermentation , Lactobacillus plantarum/growth & development , Lactobacillus/growth & development , Leuconostoc/growth & development , Polymerase Chain Reaction/methods , Colony Count, Microbial , DNA Primers , DNA, Bacterial/analysis , Food Handling/methods , Food Microbiology , RNA, Ribosomal, 16S/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...